A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%
Clinical trial NCT00151541 · COMPLETED
Trial details
- NCT number
- NCT00151541
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2005-07-01
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.